Development of an IgY-Based Treatment to Control Bovine Coronavirus Diarrhea in Dairy Calves.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
09 03 2023
Historique:
received: 06 02 2023
revised: 05 03 2023
accepted: 06 03 2023
medline: 31 3 2023
entrez: 30 3 2023
pubmed: 31 3 2023
Statut: epublish

Résumé

Bovine Coronavirus (BCoV) is a major pathogen associated with neonatal calf diarrhea. Standard practice dictates that to prevent BCoV diarrhea, dams should be immunized in the last stage of pregnancy to increase BCoV-specific antibody (Ab) titers in serum and colostrum. For the prevention to be effective, calves need to suck maternal colostrum within the first six to twelve hours of life before gut closure to ensure a good level of passive immunity. The high rate of maternal Ab transfer failure resulting from this process posed the need to develop alternative local passive immunity strategies to strengthen the prevention and treatment of BCoV diarrhea. Immunoglobulin Y technology represents a promising tool to address this gap. In this study, 200 laying hens were immunized with BCoV to obtain spray-dried egg powder enriched in specific IgY Abs to BCoV on a large production scale. To ensure batch-to-batch product consistency, a potency assay was statistically validated. With a sample size of 241, the BCoV-specific IgY ELISA showed a sensitivity and specificity of 97.7% and 98.2%, respectively. ELISA IgY Abs to BCoV correlated with virus-neutralizing Ab titers (Pearson correlation, R

Identifiants

pubmed: 36992417
pii: v15030708
doi: 10.3390/v15030708
pmc: PMC10059803
pii:
doi:

Substances chimiques

IgY 0
Powders 0
Antibodies, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Front Immunol. 2022 Jun 01;13:899617
pubmed: 35720389
Poult Sci. 2012 Dec;91(12):3091-6
pubmed: 23155018
Pol J Vet Sci. 2016;19(2):271-9
pubmed: 27487500
Arch Virol. 2006 Sep;151(9):1735-48
pubmed: 16583154
Vet Clin North Am Food Anim Pract. 2010 Jul;26(2):349-64
pubmed: 20619189
Front Vet Sci. 2021 Mar 31;8:643220
pubmed: 33869323
Int Immunopharmacol. 2019 Aug;73:293-303
pubmed: 31128529
J Vet Sci. 2014;15(1):1-17
pubmed: 24378583
Vet J. 2014 May;200(2):294-8
pubmed: 24679458
J Dairy Sci. 2002 May;85(5):1249-54
pubmed: 12086062
Front Immunol. 2022 May 10;13:881604
pubmed: 35664008
Int Immunopharmacol. 2020 Apr;81:106269
pubmed: 32036273
Vet Microbiol. 2015 Dec 31;181(3-4):221-9
pubmed: 26520931
J Vet Diagn Invest. 1996 Jan;8(1):99-105
pubmed: 9026089
Altern Lab Anim. 2005 Apr;33(2):129-54
pubmed: 16180988
Vet Clin North Am Food Anim Pract. 2012 Nov;28(3):465-81
pubmed: 23101671
Vet Immunol Immunopathol. 2004 Jul;100(1-2):7-24
pubmed: 15182992
J Vet Diagn Invest. 2010 Jul;22(4):509-17
pubmed: 20622219
Vet Clin North Am Food Anim Pract. 2010 Mar;26(1):123-46, table of contents
pubmed: 20117547
Arch Virol. 2015 Sep;160(9):2197-207
pubmed: 26100403
J Virol Methods. 2008 Aug;151(2):167-171
pubmed: 18579223
J Virol Methods. 2006 Apr;133(1):112-5
pubmed: 16325277
Sci Rep. 2022 Nov 8;12(1):19020
pubmed: 36347859
Am J Vet Res. 1979 Oct;40(10):1476-8
pubmed: 230757
Vet Clin North Am Food Anim Pract. 2009 Mar;25(1):221-7
pubmed: 19174291
J Virol. 1988 Jul;62(7):2234-7
pubmed: 3373569
Rev Argent Microbiol. 2018 Jan - Mar;50(1):23-30
pubmed: 28893529
Vet Microbiol. 2020 May;244:108693
pubmed: 32402329
Res Vet Sci. 2015 Dec;103:1-10
pubmed: 26679788
Arch Virol. 2019 Nov;164(11):2715-2724
pubmed: 31456086
Am J Vet Res. 1991 Jun;52(6):852-7
pubmed: 1652905
Trop Anim Health Prod. 2020 Sep;52(5):2761-2768
pubmed: 32488696
Vet Immunol Immunopathol. 2010 Jul;136(1-2):12-27
pubmed: 20138373
Can J Comp Med. 1978 Apr;42(2):168-71
pubmed: 208735
Pol J Vet Sci. 2013;16(2):283-91
pubmed: 23971196
Arch Virol. 1994;138(1-2):143-8
pubmed: 7980004
J Virol. 2006 Dec;80(24):12350-6
pubmed: 16971444
Vet Immunol Immunopathol. 2011 Aug 15;142(3-4):156-69
pubmed: 21652087
Med Clin (Barc). 2004;122 Suppl 1:28-34
pubmed: 14980157
Vet Clin North Am Food Anim Pract. 2012 Nov;28(3):443-64
pubmed: 23101670
Vet Microbiol. 1997 Nov;58(2-4):105-11
pubmed: 9453122
Can J Comp Med. 1984 Jul;48(3):340-2
pubmed: 6089985
Vet Rec. 1988 Sep 10;123(11):300-1
pubmed: 2848350
Am J Vet Res. 2001 Sep;62(9):1436-41
pubmed: 11560274

Auteurs

Marina Bok (M)

INCUINTA, Virology Institute and Technology Innovations, National Institute of Agricultural Technology, Buenos Aires 1686, Argentina.
CONICET, Buenos Aires C1425FQB, Argentina.
Bioinnovo S.A., Buenos Aires 1686, Argentina.

Celina G Vega (CG)

INCUINTA, Virology Institute and Technology Innovations, National Institute of Agricultural Technology, Buenos Aires 1686, Argentina.
CONICET, Buenos Aires C1425FQB, Argentina.
Bioinnovo S.A., Buenos Aires 1686, Argentina.

Matias Castells (M)

Molecular Virology Laboratory, CENUR North Litoral, Salto University Centre, University of the Republic, Salto 50000, Uruguay.
Animal Health Research, National Institute of Agricultural Research (INIA), Colonia 70006, Uruguay.

Rodney Colina (R)

Molecular Virology Laboratory, CENUR North Litoral, Salto University Centre, University of the Republic, Salto 50000, Uruguay.
Animal Health Research, National Institute of Agricultural Research (INIA), Colonia 70006, Uruguay.

Andrés Wigdorovitz (A)

INCUINTA, Virology Institute and Technology Innovations, National Institute of Agricultural Technology, Buenos Aires 1686, Argentina.
CONICET, Buenos Aires C1425FQB, Argentina.
Bioinnovo S.A., Buenos Aires 1686, Argentina.

Viviana Parreño (V)

INCUINTA, Virology Institute and Technology Innovations, National Institute of Agricultural Technology, Buenos Aires 1686, Argentina.
CONICET, Buenos Aires C1425FQB, Argentina.
Bioinnovo S.A., Buenos Aires 1686, Argentina.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH